may reduce Alzheimer’s disease risk in type 2 diabetes patients more effectively than seven other anti-diabetic drugs, offering a promising potential benefit for patients as per a study from ...

The use of SGLT2 inhibitors was associated with a significantly reduced risk for dementia and PD in patients with type 2 diabetes.

Researchers at Case Western Reserve school of Medicine looked at nearly one million patients in the U.S. with Type 2 diabetes ...

revealed that patients who were prescribed semaglutide had a "significantly lower risk" of developing Alzheimer’s compared to those taking other types of anti-diabetic medications, according to ...

Further, uncontrolled diabetes also leads to various neurological conditions in diabetic patients. “The brain complications ...

People with type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared to patients taking seven other diabetes drugs, researchers reported.

A warning has been issued over drinking habits that could actually accelerate Alzheimer’s disease. New research published in ...

They found patients prescribed semaglutide had a significantly lower risk for Alzheimer's disease, compared to those who had taken any of seven other anti-diabetic medications, including other ...

When they analyzed the data, they found that semaglutide use was associated with 40% to 70% less risk of being diagnosed with Alzheimer’s in patients with type 2 diabetes. This was in comparison ...

researchers examined three years of electronic health records for more than one million Americans who had type 2 diabetes and no history of Alzheimer’s disease. All of the patients had at least ...